I agree that this site is using cookies. You can find further informations here.
X
Naganuma, Miyoko
13  results:
Search for persons X
?
1

Population pharmacokinetic analysis and dosage recommendati..:

Hirai, Toshinori ; Kasai, Hidefumi ; Naganuma, Miyoko..
BMC Pharmacology and Toxicology.  23 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
2

Clinical Outcomes of Direct Oral Anticoagulants and Warfari..:

Naganuma, Miyoko ; Shiga, Tsuyoshi ; Hagiwara, Nobuhisa
Drugs - Real World Outcomes.  7 (2020)  4 - p. 325-335 , 2020
Link: https://doi.org/10.1007/..
 
?
3

Effectiveness and safety of dabigatran versus warfarin in "..:

Naganuma, Miyoko ; Shiga, Tsuyoshi ; Nagao, Takehiko...
Journal of Arrhythmia.  33 (2016)  2 - p. 107-110 , 2016
Link: https://doi.org/10.1016/..
 
?
4

Persistence of non‐vitamin K antagonist oral anticoagulant ..:

Shiga, Tsuyoshi ; Naganuma, Miyoko ; Nagao, Takehiko...
Journal of Arrhythmia.  31 (2015)  6 - p. 339-344 , 2015
Link: https://doi.org/10.1016/..
 
?
5

Clinical outcome in Japanese elderly patients with non-valv..:

Naganuma, Miyoko ; Shiga, Tsuyoshi ; Sato, Kumi...
Thrombosis Research.  130 (2012)  1 - p. 21-26 , 2012
Link: https://doi.org/10.1016/..
 
?
6

Clinical Outcome in Patients With Paroxysmal or Persistent ..:

Shiga, Tsuyoshi ; Suzuki, Atsushi ; Naganuma, Miyoko...
Circulation Journal.  75 (2011)  6 - p. 1334-1342 , 2011
Link: https://doi.org/10.1253/..
 
?
7

Role of Desethylamiodarone in the Anticoagulant Effect of C..:

Naganuma, Miyoko ; Shiga, Tsuyoshi ; Nishikata, Kaori...
Journal of Cardiovascular Pharmacology and Therapeutics.  6 (2001)  4 - p. 363-367 , 2001
Link: https://doi.org/10.1177/..
 
?
8

Clinical Outcomes of Direct Oral Anticoagulants and Warfari..:

Naganuma, Miyoko ; Shiga, Tsuyoshi ; Hagiwara, Nobuhisa
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581660/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
9

Effectiveness and safety of dabigatran versus warfarin in "..:

Naganuma, Miyoko ; Shiga, Tsuyoshi ; Nagao, Takehiko...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388055/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
10

Population pharmacokinetic analysis and dosage recommendati..:

Toshinori Hirai ; Hidefumi Kasai ; Miyoko Naganuma..
https://doi.org/10.1186/s40360-022-00552-y.  , 2022
Link: https://doi.org/10.1186/..
 
?
11

Clinical Outcomes of Direct Oral Anticoagulants and Warfari..:

Miyoko Naganuma ; Tsuyoshi Shiga ; Nobuhisa Hagiwara
https://doi.org/10.1007/s40801-020-00209-4.  , 2020
Link: https://doi.org/10.1007/..
 
?
12

Effectiveness and safety of dabigatran versus warfarin in "..:

Miyoko Naganuma, PhD ; Tsuyoshi Shiga, MD ; Takehiko Nagao, MD...
http://www.sciencedirect.com/science/article/pii/S1880427616300813.  , 2017
Link: https://doi.org/10.1016/..
 
?
13

Persistence of non-vitamin K antagonist oral anticoagulant ..:

Tsuyoshi Shiga, MD ; Miyoko Naganuma, BSc ; Takehiko Nagao, MD...
http://www.sciencedirect.com/science/article/pii/S1880427615000575.  , 2015
Link: https://doi.org/10.1016/..
 
1-13